Efforts to ease the symptoms of autism are beginning to ramp up, with promising candidates in various stages of testing.
A partial mutation that leads to a milder form of fragile X syndrome causes deficits in learning and memory in mice, and alters the connections between their neurons, according to a study published in January in Neurobiology of Disease.
Children with autism or attention deficit hyperactivity disorder (ADHD) are both more motivated by money than by praise, according to a study published in January in the Journal of Child Psychology and Psychiatry.
The National Institutes of Health is adding a new $1 billion institute for early-stage drug development. But the agency’s plan to fund it by closing the National Center for Research Resources is causing some consternation.
A long list of autism researchers has officially rebuked le packing, a barbaric autism therapy that’s well known in France.
A new intervention that teaches toddlers skills in a real-world environment — a playgroup rather than a one-on-one interaction with a researcher, for instance — more than doubles their ability to imitate others, according to a January study in The Journal of Child Psychology and Psychiatry.
Children with autism spend less time in the rapid eye movement stage of sleep than do either controls or those with developmental delays, according to a November report in the Archives of Pediatrics & Adolescent Medicine.
The ‘intense world theory’ says autism stems from hyper-sensitive reactions to the world, allowing the individual to zoom in on tiny details, but ignore the bigger picture.
High levels of serotonin in the womb may up the risk of autism in the child, according to a study published in December in the American Journal of Medical Genetics.
Mice exposed to an epilepsy drug show several features of autism, including abnormal social interactions, repetitive behaviors and patterns of super-fast brain waves, called gamma oscillations, according to a study published 15 December in Biological Psychiatry.
A new drug appears to relieve symptoms of fragile X syndrome by blocking the over-production of a key protein in a subset of people with the disorder, according to a 6 January study in Science Translational Medicine.
